Piramal Pharma Solutions
Stuart Needleman has an extensive work history in the pharmaceutical industry. Stuart began their career in 1997 at ChiRex Inc. as Vice President of Business Development. Stuart then joined Aptuit in 2006 as Vice President of Sales and Marketing, and later assumed the roles of President of Scientific Operations and President and Chief Operating Officer. In 2014, Needleman became the President of Laurus Synthesis. Their most recent position was at Piramal Pharma Solutions, where they served as Chief Commercial Officer before being promoted to Chief Patient Centricity Officer in 2020.
Stuart Needleman graduated from Rensselaer Polytechnic Institute in 1981 with a Bachelors of Science degree in Chemical Engineering. Stuart later pursued a Master of Business Administration (M.B.A.) at the same institution, although the exact years are unknown.
This person is not in any offices
Piramal Pharma Solutions
3 followers
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug product. Our track record as a trusted service provider with experience across varied technologies makes us a partner of choice for innovator and generic companies worldwide.